Literature DB >> 32687246

miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro.

Seyed Ali Nabipoorashrafi1, Navid Shomali2,3,4, Leila Sadat-Hatamnezhad5, Mahmoud Mahami-Oskouei6, Javad Mahmoudi7, Babak Sandoghchian Shotorbani8, Morteza Akbari3, Huaxi Xu9, Siamak Sandoghchian Shotorbani3,4,9.   

Abstract

Melanoma is a serious form of skin cancers begins in the melanocyte. Micro-RNAs are small noncoding RNA with 19 to 25 nucleotides in length involves in the regulation of a wide range of biological processes. MicroRNAs are affected by an aberrant epigenetic alteration in the tumors that may lead to their dysregulation and formation of cancer. Recently, dysregulation of numerous microRNAs has been reported in different types of cancer. The present study focused on the role of miR-143 in carcinogenesis of melanoma cancer. Here, we evaluated the expression level of miR-143 in three melanoma cell lines in comparison with the normal human epidermal melanocyte cell line. Then, miR-143 gene plasmid transfected into the WM115 cell line, for having the lowest expression of miR-143. In addition, the effect of miR-143 transfection on mRNA and protein levels of metastasis-related genes was performed along with MTT assay, wound healing assay, and flow cytometry. The results showed that mRNA and protein expression levels of metastasis-related genes including MMP-9, E-cadherin, Vimentin, and CXCR4 have been reduced following transfection of miR-143. Moreover, the results of the scratch test showed that miR-143 re-expression inhibited cell migration. Also, the role of miR-143 in the induction of apoptosis and inhibition of proliferation by flow cytometry and MTT was confirmed. As a result, the present study showed that miR-143 was involved in metastatic and apoptotic pathways, suggesting that miR-143 acts as a tumor-suppressor microRNA in melanoma cancer.
© 2020 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  apoptosis; melanoma; miR-143; migration; proliferation

Year:  2020        PMID: 32687246     DOI: 10.1002/iub.2345

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  9 in total

Review 1.  A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview.

Authors:  Ahmad Saburi; Mohammad Saeed Kahrizi; Navid Naghsh; Hasti Etemadi; Ahmet İlhan; Ali Adili; Shadi Ghoreishizadeh; Rozita Tamjidifar; Morteza Akbari; Gülinnaz Ercan
Journal:  J Ovarian Res       Date:  2022-07-07       Impact factor: 5.506

Review 2.  MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers.

Authors:  Mehdi Sajjadi-Dokht; Talar Ahmad Merza Mohamad; Heshu Sulaiman Rahman; Marwah Suliman Maashi; Svetlana Danshina; Navid Shomali; Saeed Solali; Faroogh Marofi; Elham Zeinalzadeh; Morteza Akbari; Ali Adili; Ramin Aslaminabad; Majid Farshdousti Hagh; Mostafa Jarahian
Journal:  Genes Dis       Date:  2021-12-03

Review 3.  CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.

Authors:  Roozbeh Moghaddar; Amirhossein Fakhre Yaseri; Sadegh Shojaei Baghini; Zhanna R Gardanova; Saeme Azizi Hassan Abadi; Burhan Abdullah Zaman; Ahmet İlhan; Navid Shomali; Ali Adili
Journal:  Cell Mol Biol Lett       Date:  2022-05-04       Impact factor: 8.702

Review 4.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

Review 5.  Exploring the role of non-coding RNAs in autophagy.

Authors:  Soudeh Ghafouri-Fard; Hamed Shoorei; Mahdi Mohaqiq; Jamal Majidpoor; Mohammad Amin Moosavi; Mohammad Taheri
Journal:  Autophagy       Date:  2021-02-18       Impact factor: 13.391

Review 6.  The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics.

Authors:  Elham Zeinalzadeh; Alexey Valerievich Yumashev; Heshu Sulaiman Rahman; Faroogh Marofi; Navid Shomali; Hossein Samadi Kafil; Saeed Solali; Mehdi Sajjadi-Dokht; Sajjad Vakili-Samiani; Mostafa Jarahian; Majid Farshdousti Hagh
Journal:  Front Genet       Date:  2021-12-21       Impact factor: 4.599

7.  Exploration of the Effect on Genome-Wide DNA Methylation by miR-143 Knock-Out in Mice Liver.

Authors:  Xingping Chen; Junyi Luo; Jie Liu; Ting Chen; Jiajie Sun; Yongliang Zhang; Qianyun Xi
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 6.208

8.  Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting BMPR1A in polycystic ovary syndrome.

Authors:  Yuanyuan Zhao; Shuhong Pan; Yunying Li; Xiaohua Wu
Journal:  Sci Rep       Date:  2022-03-14       Impact factor: 4.996

Review 9.  Potential of chimeric antigen receptor (CAR)-redirected immune cells in breast cancer therapies: Recent advances.

Authors:  Marzieh Nikoo; Mohammad Rudiansyah; Dmitry Olegovich Bokov; Nurlan T Jainakbaev; Wanich Suksatan; Mohammad Javed Ansari; Lakshmi Thangavelu; Supat Chupradit; Amir Zamani; Ali Adili; Navid Shomali; Morteza Akbari
Journal:  J Cell Mol Med       Date:  2022-06-28       Impact factor: 5.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.